|
|
|
Volumn 6, Issue 10-11, 1994, Pages 461-475
|
|
Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase
a
|
|
Author keywords
DT diaphorase; enzyme directed bioreductive drugs; quinones
|
|
Indexed keywords
5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE;
5 (1 AZIRIDINYL) 3 HYDROXYMETHYL 2 (3 HYDROXY 1 PROPENYL) 1 METHYL 4,7 INDOLEDIONE;
ANTINEOPLASTIC ANTIBIOTIC;
DIAZIQUONE;
MITOMYCIN A;
MITOMYCIN B;
MITOMYCIN C;
PORFIROMYCIN;
QUINONE DERIVATIVE;
RB 91007;
RB 91008;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);
TIRAPAZAMINE;
UNCLASSIFIED DRUG;
AEROBIC METABOLISM;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CELL HYPOXIA;
CONFERENCE PAPER;
DRUG CYTOTOXICITY;
DRUG METABOLISM;
DRUG SELECTIVITY;
DRUG STRUCTURE;
ENZYME ACTIVATION;
ENZYME SUBSTRATE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MOUSE;
NONHUMAN;
OXIDATION REDUCTION REACTION;
PRIORITY JOURNAL;
RAT;
SOLID TUMOR;
|
|
EID: 0028645493
PISSN: 09650407
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (142)
|
|
References (0)
|
